EMIS Insights | Latin America Pharma and Healthcare Sector Report 2021-2025
What does this sample report offer?
Latin America was hit particularly hard by the COVID-19 pandemic, having about a fifth of the number of cases and every fourth COVID-19-related death globally at the end of February 2021. Amidst a new wave of the pandemic since late 2020 and healthcare systems on the brink of a collapse, a major silver lining is the launch of the vaccination campaign in virtually all countries in the region. And on the rocky road of vaccine rollout, one Latin American country sets a global example.
This report provides a comprehensive sector overview, with this sample providing access to:
- Regional overview for Brazil, Mexico, Argentina, Colombia and Chile
- Demographic trends
- Health profiles and infrastructure
- Drug production, trade and external sales
- The COVID-19 pandemic in Latin America
About EMIS Insights
EMIS operates in and reports on countries where high reward goes hand-in-hand with high risk. We bring you time-sensitive, hard-to-get, relevant news, research and analytical data, peer comparisons and more for over 120 emerging markets. Our EMIS Insights Report suite constitutes just a proportion of our deep emerging markets information platform, which you can learn more about
here. Alternatively, explore our pay-as-you-go offerings with our EMIS Insights Industry Reports
here.